My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
April 2010
Patient Care and Science
Special Review Panel Upholds IDSA’s 2006 Lyme Disease Guidelines

After spending more than a year reviewing the evidence relating to Lyme disease, a special independent Review Panel has unanimously agreed that no changes need to be made to IDSA’s 2006 Lyme disease guidelines. The panel determined that the guidelines were based on the best evidence available at the time and also supported by the evidence that has been published since. Released April 22, the Review Panel’s final report is available on IDSA’s website.

The special review was conducted following a voluntary agreement with Connecticut Attorney General Richard Blumenthal, who challenged the process used to develop IDSA’s 2006 Lyme disease guidelines on behalf of a group of patients and advocates and a small group of physicians who support a different treatment model. The Attorney General never questioned the scientific validity of IDSA’s guidelines but alleged conflicts of interest and a failure to consider divergent points of view. IDSA maintains that these assertions were unfounded. However, IDSA voluntarily agreed to a special, one-time review, confident that the guidelines and the process behind them would be validated. 
How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

Top Stories
From the President: Working with our Federal Partners to Address Antibiotic Resistance
Health Reform Will Affect How ID Physicians Are Paid
IDSA Journal Club
Patient Care and Science
Special Review Panel Upholds IDSA’s 2006 Lyme Disease Guidelines
EIN Update: Invasive Group A Streptococcal (GAS) Infections
Drug Approvals, Recalls, Adverse Events Update
Practice Management
Medicare Again Postpones Physician Payment Cuts
New Medicare ID Utilization Data Now Available
Global ID
New MDR-TB Treatment Program Has Early Success
Policy & Advocacy
FDA Advisory Committees Seek New Members
Your Colleagues
Welcome, New Members!
Education & Resources
Redesigned ID/HIV Career Center Offers New Features
Revised CPT Coding Resources Coming Soon
Slides from Billing and Coding Webinar Now Available

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.